PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24007746-15	2013	INTERPRETATION: A short, four-cycle regimen of docetaxel and cyclophosphamide combined with trastuzumab could be an option for adjuvant treatment of women with lower risk HER2-amplified early breast cancer, irrespective of TOP2A status.	Cyclophosphamide	61-77	DNA topoisomerase II alpha	Homo sapiens	223-228	
25642443-3	2014	METHODS: The TOP2A gene status was examined by FISH in biopsies from 18 patients who received anthracycline and cyclophosphamide before surgery.	Cyclophosphamide	112-128	DNA topoisomerase II alpha	Homo sapiens	13-18	
19620488-2	2009	We determined the status of the HER2 and TOP2A genes in a large cohort of breast cancer patients treated with adjuvant doxorubicin (A) and cyclophosphamide (C).	Cyclophosphamide	139-155	DNA topoisomerase II alpha	Homo sapiens	41-46